Skip to content

Clinical trials

Central Nervous System Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: Netherlands Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20151
20162
20191
20201
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
AC Immune SA1
AstraZeneca1
BBB-Therapeutics B.V.1
Bial R&D Investments, S.A.1
Eli Lilly and Company1
GlaxoSmithKline1
Novartis Pharmaceuticals1
University College Cork1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases13
Brain Diseases10
Nervous System Diseases9
Neurodegenerative Diseases6
Alzheimer Disease4
Basal Ganglia Diseases4
Parkinson Disease4
Parkinsonian Disorders4
Dementia3
Mental Disorders2

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.